VACCINATION AGAINST EPSTEIN-BARR VIRUS: CURRENT PROGRESS AND FUTURE STRATEGIES
- 1 June 1986
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 327 (8495) , 1425-1427
- https://doi.org/10.1016/s0140-6736(86)91565-5
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Serological mass survey for early detection of nasopharyngeal carcinoma in wuzhou city, chinaInternational Journal of Cancer, 1982
- Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective studyNature, 1978
- Epstein-Barr Virus — Is It Time To Develop a Vaccine Program?JNCI Journal of the National Cancer Institute, 1976
- EB Viral Genomes in Epithelial Nasopharyngeal Carcinoma CellsNature New Biology, 1973
- Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the NasopharynxNature, 1970
- On the epidemiology of nasopharyngeal carcinomaInternational Journal of Cancer, 1970
- Protection against Marek's Disease by Vaccination with a Herpesvirus of TurkeysPublished by JSTOR ,1970
- Immunization against Marek's Disease using a Live Attenuated VirusNature, 1969
- PRECIPITATING ANTIBODY IN HUMAN SERUM TO AN ANTIGEN PRESENT IN CULTURED BURKITT'S LYMPHOMA CELLSProceedings of the National Academy of Sciences, 1966
- VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Lancet, 1964